???global.info.a_carregar???
Manoj Kumar Mandal. Completed the Mestrado in Bologna Master Degree (Microbiology) in 2019/11/29 by Universidade de Lisboa Instituto Superior Técnico, Postgraduate Certificate in Master of Science (Applied Biomedical Science) in 2014/06/18 by University of Greenwich Faculty of Engineering and Science and Bachelor in Bachelor of Science (Applied Biotechnology) in 2011/07/08 by Sikkim Manipal University Directorate of Distance Education. Worked as Visiting Researcher in Universidade de Lisboa Instituto de Investigação do Medicamento. Worked at Associação para o Desenvolvimento do Ensino e Investigação da Microbiologia(ADEIM). Works in the area(s) of Biological Sciences with emphasis on Microbiology, Molecular Biology and Cell Biology, and Medical Health Sciences with emphasis on infectious diseases, Immunology and Biotechnology. Currently, Phd fellow (Grant from FCT), working on the proposed research on infectious diseases, including Mtb and HIV.
Identification

Personal identification

Full name
Manoj Kumar Mandal

Citation names

  • Mandal, M

Author identifiers

Ciência ID
7219-8D5B-BFAB
ORCID iD
0000-0003-3997-9618
Scopus Author Id
57222736661

Email addresses

  • mmandal@ff.ulisboa.pt (Professional)
  • manoj2biomedical@gmail.com (Personal)

Telephones

Mobile phone
  • 912567699 (Personal)

Addresses

  • Rua Jose Relvas 8, 1ESQ, 1900-282, Lisboa, Lisbon, Portugal (Personal)

Knowledge fields

  • Natural sciences - Biological Sciences - Microbiology
  • Natural sciences - Biological Sciences - Molecular Biology
  • Medical and Health Sciences - Basic Medicine - Immunology

Languages

Language Speaking Reading Writing Listening Peer-review
Nepali (Mother tongue)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Portuguese Intermediate (B1) Upper intermediate (B2) Intermediate (B1) Intermediate (B1) Intermediate (B1)
Education
Degree Classification
2021/11/01 - 2025/11/01
Ongoing
PhD in Pharmacy (Doutoramento)
Major in Microbiology and Immunology
Universidade de Lisboa Faculdade de Farmácia, Portugal
2017/02/18 - 2019/11/29
Concluded
Bologna Master Degree (Mestrado)
Major in Microbiology
Universidade de Lisboa Instituto Superior Técnico, Portugal
"Contribution to the identification of surface exposed immunogenic proteins in bacteria from burkholderia cepacia complex" (THESIS/DISSERTATION)
16 (Very Good: 16/20)
2016/11/07 - 2016/11/15
Concluded
Training course: Scientific Writing & Publication (Outros)
Universidade de Lisboa Instituto Superior Técnico, Portugal
Approved (1.5 ECTS)
2013/02/18 - 2014/06/18
Concluded
Master of Science (Postgraduate Certificate)
Major in Applied Biomedical Science
University of Greenwich Faculty of Engineering and Science, United Kingdom
"Potential New Treatments for cutaneous Leishmaniasis" (THESIS/DISSERTATION)
Pass
2008/08/06 - 2011/07/08
Concluded
Bachelor of Science (Bachelor)
Major in Applied Biotechnology
Sikkim Manipal University Directorate of Distance Education, India
17 (A: Excellent, 17/20)
Affiliation

Science

Category
Host institution
Employer
2021/11/01 - Current Researcher (Research) Universidade de Lisboa Faculdade de Farmácia, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2021/02/01 - 2021/10/31 Researcher (Research) Associação para o Desenvolvimento do Ensino eInvestigação da Microbiologia, Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal
2019/12/09 - 2021/10/30 Visiting Researcher (Research) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2018/04/18 - 2019/09/08 Research Trainee (Research) Universidade de Lisboa Instituto Superior Técnico, Portugal
Universidade de Lisboa Instituto Superior Técnico, Portugal
2017/07/31 - 2017/09/29 Research Trainee (Research) Carl von Ossietzky Universität Oldenburg, Germany
Carl von Ossietzky Universität Oldenburg Institut für Chemie und Biologie des Meeres, Germany
Projects

Grant

Designation Funders
2021/11/01 - Current “Developing host-directed-therapies for Mycobacterium tuberculosis infection and HIV co-infection based on Cystatins manipulation
2021.07978.BD
PhD Student Fellow
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2017/07/31 - 2017/09/29 Virus Dynamics Are Influenced by Season, Tides and Advective Transport in Intertidal, Permeable Sediments
Researcher
Carl von Ossietzky Universität Oldenburg Institut für Chemie und Biologie des Meeres, Germany
Deutsche Forschungsgemeinschaft
Concluded

Contract

Designation Funders
2021/02/01 - 2021/10/30 Diagnosis of infections by SARS-CoV-2/COVID-19
BI 2020/006
Research Fellow
Universidade de Lisboa Faculdade de Farmácia, Portugal
Ongoing
Outputs

Publications

Conference abstract
  1. Mandal, M; Pires, David; ANES, ELSA. "Development and characterisation of a 3D cell culture model of the tuberculosis granuloma". Paper presented in 18th International Congress of Immunology (IUIS 2023), Cape town, 2024.
    Accepted
  2. Mandal, MK; Seixas, AMM; Leitão, JH; Rodríguez Ortega, MJ. "Surface-shaving approaches to identify surface-exposed and immunogenic proteins from Burkholderia cenocepacia live cells.". Paper presented in 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Paris, 2019.
    Accepted
Journal article
  1. Manoj Mandal; David Pires; Maria João Catalão; José Miguel Azevedo-Pereira; Elsa Anes. "Modulation of Cystatin F in Human Macrophages Impacts Cathepsin-Driven Killing of Multidrug-Resistant Mycobacterium tuberculosis". Microorganisms (2023): https://doi.org/10.3390/microorganisms11071861.
    10.3390/microorganisms11071861
  2. Anes, Elsa; Pires, David; Mandal, Manoj; Azevedo-Pereira, José Miguel. "ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis". Biomolecules 13 6 (2023): 968. http://dx.doi.org/10.3390/biom13060968.
    10.3390/biom13060968
  3. Pires, David; Mandal, Manoj; Matos, Ana I.; Peres, Carina; Catalão, Maria João; Azevedo-Pereira, José Miguel; Satchi-Fainaro, Ronit; Florindo, Helena F.; Anes, Elsa. "Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis". Antibiotics 12 4 (2023): 729. http://dx.doi.org/10.3390/antibiotics12040729.
    10.3390/antibiotics12040729
  4. José Miguel Azevedo-Pereira; David Pires; Marta Calado; Manoj Mandal; Quirina Santos-Costa; Elsa Anes. "HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an “Emerging Syndemic”". Microorganisms (2023): https://doi.org/10.3390/microorganisms11040853.
    10.3390/microorganisms11040853
  5. David Pires; Manoj Mandal; Jacinta Pinho; Maria João Catalão; António José Almeida; José Miguel Azevedo-Pereira; Maria Manuela Gaspar; Elsa Anes. "Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms24021142.
    10.3390/ijms24021142
  6. Anes, Elsa; Pires, David; Mandal, Manoj; Azevedo-Pereira, José Miguel. "Spatial localization of cathepsins: Implications in immune activation and resolution during infections". Frontiers in Immunology 13 (2022): http://dx.doi.org/10.3389/fimmu.2022.955407.
    10.3389/fimmu.2022.955407
  7. Pires, David; Valente, Sofia; Calado, Marta; Mandal, Manoj; Azevedo-Pereira, José Miguel; Anes, Elsa. "Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection". Frontiers in Immunology 12 (2021): http://dx.doi.org/10.3389/fimmu.2021.647728.
    Published • 10.3389/fimmu.2021.647728
  8. Anes, Elsa; Pires, David; Velez, Tomás; Azevedo-Pereira, JM. "Modulation of Cystatin C in human macrophages improves anti-mycobacterial immune responses to Mycobacterium tuberculosis infection and co-infection with HIV.". Frontiers in Immunology (2021):
    Open access • Published • 10.3389/fimmu.2021.742822
  9. Sousa, Sílvia A.; Seixas, António M.M.; Mandal, Manoj; Rodríguez-Ortega, Manuel J.; Leitão, Jorge H.. "Characterization of the Burkholderia cenocepacia J2315 Surface-Exposed Immunoproteome". Vaccines 8 3 (2020): 509. http://dx.doi.org/10.3390/vaccines8030509.
    Open access • Published • 10.3390/vaccines8030509
Preprint
  1. Anes, Elsa; Pires, David; Mandal, Manoj; Azevedo-Pereira, José Miguel. "ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis and a Target for New Therapeutic Interventions". 2023. http://dx.doi.org/10.20944/preprints202305.0979.v2.
    10.20944/preprints202305.0979.v2
Thesis / Dissertation
  1. Mandal, Manoj. "Contribution to the identification of surface-exposed immunogenic proteins of bactéria from the Burkholderia cepacia complex.". Master, Universidade de Lisboa Instituto Superior Técnico, 2019. https://fenix.tecnico.ulisboa.pt/downloadFile/1689244997259884.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2021/10/19 An alternative treatment to Pseudomonas aeruginosa chronic lung infection: Lytic Phage-based therapy using an exosome-liposome hybrid encapsulation during Hybrid Course Novel Challenges in Toxicology Hybrid Course Novel Challenges in Toxicology
Faculty of Pharmacy, Universidade de Lisboa (Lisbon, Portugal)
2017/08/25 Microbial ActivitiesIn Marine Sediments (Viral production in tidal permeable sediments of the Wadden Sea) IAESTE Student Group Presentation
Institute for Chemistry and Biology of the Marine Environment (ICBM)- Team Paleomicrobiology (Oldenberg, Germany)

Event participation

Activity description
Type of event
Event name
Institution / Organization
2023/06/27 - 2023/06/27 Presented Poster “Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis” at the “Jornadas Científicas da Universidade de Lisboa 2023
Conference
Universidade de Lisboa, Portugal
2023/06/26 - 2023/06/26 Presented poster Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis presented at the iMed.Ulisboa Meeting 2023
Meeting
Universidade de Lisboa Faculdade de Farmácia, Portugal
2023/03/31 - 2023/04/01 Presented poster Liposomal delivery of repurposed antiviral drug saquinavir to macrophages as a host-directed therapy for tuberculosis at the iMed.Ulisboa Meeting 2023.
Conference
2023/03/31 - 2023/04/01 Presented poster Liposomal delivery of repurposed antiviral drug saquinavir to macrophages as a host-directed therapy for tuberculosis presented at CIIS NATIONAL MEETING: Interdisciplinary Health Care 2023, Faculdade de Medicina da Universidade Católica Portuguesa, Portugal.
Meeting
2023/02/27 - 2023/03/01 Active participation in the conference "Vaccine Development-the pre- and post- COVID-19 era", Pasteur Institute, France, Paris
Conference
"Vaccine Development"-the pre- and post- COVID-19 era, Pasteur Institute, France, Paris
Institut Pasteur, France
2022/09/12 - 2022/09/16 Participated and presented poster Developing therapeutic strategies against Mycobacterium tuberculosis infection based on manipulation of protease inhibitors at the EMBO workshop on Tuberculosis 2022.
Congress
EMBO workshop on Tuberculosis 2022 (Paris, France)
2022/05/16 - 2022/05/18 Presented poster Repurposing Saquinavir for host-directed therapy to control Mycobacterium tuberculosis infection at the annual meeting of science, technology and innovation in Portugal Ciência 2022
Conference
The annual meeting of science, technology and innovation in Portugal Ciência 2022
2021/09/17 - 2021/09/24 Workshop for flow cytometry analysis
Workshop
iMed Workshop on FCS Express for flow cytometry analysis 2021
Universidade de Lisboa Faculdade de Farmácia, Portugal
2021/06/16 - 2021/07/09 Presented Poster entitled "Repurposing Saquinavir for host-directed therapy to control Mycobacterium Tuberculosis Infection.
Meeting
iMed.Ulisboa Meeting 2021
Universidade de Lisboa Faculdade de Farmácia, Portugal
2020/01/31 - 2020/01/31 Member of the group (Host-Pathogen Interactions Unit, iMed-Ulisboa) presenting at II Simpósio de Investigação em Tuberculose e Micobactérias Não Tuberculosas em Portugal 31 de janeiro de 2020
Conference
II Simpósio de Investigação em Tuberculose e Micobactérias Não Tuberculosas em Portugal
Universidade de Lisboa Faculdade de Farmácia, Portugal
2019/11/27 - 2019/11/27 Member of the group (Group de Ciências Biológicas, Centro de Engenharia Biológica e Química, IST, Lisboa) presenting at 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Conference
30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Committee member

Activity description
Role
Institution / Organization
2010/03/04 - 2012/09/17 Motivated for promotion of biotechnology in Nepal.
Member
Biotechnology Society of Nepal, Nepal
Distinctions

Award

2023 Best poster award at CIIS NATIONAL MEETING: Interdisciplinary Health Care 2023 by Faculdade de Medicina da Universidade Católica Portuguesa, Portugal.